Lucia Chen
996  Ergebnisse:
Personensuche X
?
1

Evaluation of the frailty characteristics and clinical outc..:

Faouzi Djebbari ; Alexandros Rampotas ; Fotios Panitsas...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752006/?tool=EBI.  , 2022
 
?
4

A recommendation and risk classification system for connect..:

Harrison Wilde ; Lucia L. Chen ; Austin Nguyen...
https://www.cambridge.org/core/product/identifier/S2632324920000231/type/journal_article.  , 2021
 
?
5

Socioeconomic Factors and Racial and Ethnic Differences in ..:

Jenny I. Shen ; Lucia Chen ; Sitaram Vangala...
http://www.sciencedirect.com/science/article/pii/S2590059520300236.  , 2020
 
?
7

The Eating and Cooking Healthy (TEACH) Kitchen: A Research ..:

Sashia White ; Roberto Alva-Ruiz ; Lucia Chen...
https://digitalcommons.georgiasouthern.edu/jgpha/vol6/iss5/20.  , 2016
 
?
8

Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for p..:

Andrea Alemany ; Pere Millat-Martinez ; Marc Corbacho-Monné...
http://www.sciencedirect.com/science/article/pii/S2589537023000755.  , 2023
 
?
9

Overall survival (OS) by frailty (frail vs. intermediate or..:

Faouzi Djebbari (6004379) ; Alexandros Rampotas (11933847) ; Fotios Panitsas (11933850)...
https://figshare.com/articles/figure/Overall_survival_OS_by_frailty_frail_vs_intermediate_or_fit_46_months_vs_not_reached_HR_1_94_95_CI_0_89_4_2_p_0_094_/18175686.  , 2022
 
?
10

Reasons for discontinuation of first line VCD myeloma thera..:

Faouzi Djebbari (6004379) ; Alexandros Rampotas (11933847) ; Fotios Panitsas (11933850)...
https://figshare.com/articles/dataset/Reasons_for_discontinuation_of_first_line_VCD_myeloma_therapy_in_the_total_cohort_in_MRP_subgroups_frail_vs_intermediate_or_fit_and_in_co-morbidity_subgroups_/18175701.  , 2022
 
?
11

Toxicities associated with VCD therapy in the total cohort:

Faouzi Djebbari (6004379) ; Alexandros Rampotas (11933847) ; Fotios Panitsas (11933850)...
https://figshare.com/articles/dataset/Toxicities_associated_with_VCD_therapy_in_the_total_cohort_/18175710.  , 2022
 
?
12

Inclusion/exclusion in the cohort and frailty score categor..:

Faouzi Djebbari (6004379) ; Alexandros Rampotas (11933847) ; Fotios Panitsas (11933850)...
https://figshare.com/articles/figure/Inclusion_exclusion_in_the_cohort_and_frailty_score_categories_/18175683.  , 2022
 
?
13

Progression-free survival (PFS) by frailty (frail vs. inter..:

Faouzi Djebbari (6004379) ; Alexandros Rampotas (11933847) ; Fotios Panitsas (11933850)...
https://figshare.com/articles/figure/Progression-free_survival_PFS_by_frailty_frail_vs_intermediate_or_fit_11_8_vs_9_9_months_HR_0_99_95_CI_0_61_1_61_P_0_982_/18175692.  , 2022
 
?
14

Response rates to first line VCD myeloma therapy in the tot..:

Faouzi Djebbari (6004379) ; Alexandros Rampotas (11933847) ; Fotios Panitsas (11933850)...
https://figshare.com/articles/dataset/Response_rates_to_first_line_VCD_myeloma_therapy_in_the_total_cohort_in_MRP_subgroups_frail_vs_intermediate_or_fit_and_in_co-morbidity_subgroups_/18175704.  , 2022
 
?
15

Univariate (UVA) and multivariate (MVA) analyses for PFS an..:

Faouzi Djebbari (6004379) ; Alexandros Rampotas (11933847) ; Fotios Panitsas (11933850)...
https://figshare.com/articles/dataset/Univariate_UVA_and_multivariate_MVA_analyses_for_PFS_and_OS_/18175707.  , 2022
 
1-15